Research programme: anti-inflammatory therapeutics - Trino Therapeutics
Latest Information Update: 28 Mar 2023
At a glance
- Originator Trino Therapeutics
- Class Anti-inflammatories; Benzoates; Indans; Small molecules
- Mechanism of Action Immunomodulators; Mast cell stabilisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; Crohn's disease; Lung disorders; Ulcerative colitis
Most Recent Events
- 28 Mar 2023 Discontinued - Preclinical for Autoimmune disorders in United Kingdom (PO)
- 28 Mar 2023 Discontinued - Preclinical for Crohn's disease in United Kingdom (PO)
- 28 Mar 2023 Discontinued - Preclinical for Lung disorders in United Kingdom (PO)